The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Quality by Design-Driven Zeta Potential Optimisation Study of Liposomes with Charge Imparting Membrane Additives
Open accessAbstract
Liposomal formulations, as versatile nanocarrier systems suitable for targeted delivery, have a highly focused role in the therapy development of unmet clinical needs and diagnostic imaging techniques. Formulating nanomedicine with suitable zeta potential is an essential but challenging task. Formulations with a minimum ±30 mV zeta potential are considered stable. The charge of the phospholipid bilayer can be adjusted with membrane additives. The present Quality by Design-derived study aimed to optimise liposomal formulations prepared via the thin-film hydration technique by applying stearylamine (SA) or dicetyl phosphate (DCP) as charge imparting agents. This 32 fractional factorial design-based study determined phosphatidylcholine, cholesterol, and SA/DCP molar ratios for liposomes with characteristics meeting the formulation requirements. The polynomials describing the effects on the zeta potential were calculated. The optimal molar ratios of the lipids were given as 12.0:5.0:5.0 for the SA-PBS pH 5.6 (optimised sample containing stearylamine) and 8.5:4.5:6.5 for the DCP-PBS pH 5.6 (optimised sample containing dicetyl phosphate) particles hydrated with phosphate-buffered saline pH 5.6. The SA-PBS pH 5.6 liposomes had a vesicle size of 108 ± 15 nm, 0.20 ± 0.04 polydispersity index, and +30.1 ± 1.2 mV zeta potential, while these values were given as 88 ± 14 nm, 0.21 ± 0.02, and −36.7 ± 3.3 mV for the DCP-PBS pH 5.6 vesicles. The prepared liposomes acquired the requirements of the zeta potential for stable formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nakhaei, P., Margiana, R., Bokov, D. O., Abdelbasset, W. K., Jadidi Kouhbanani, M. A., Varma, R. S., Marofi, F., Jarahian, M., & Beheshtkhoo, N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.705886 · Cited by 479
RetractedDanaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · cited 2×
“The liposomes were prepared via the thin-film hydration method [11] with modifications based on our prior findings [21].”
BackgroundMethodEffect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Clogston, J. D., & Patri, A. K. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-60327-198-1_6 · Cited by 1,324
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2)
Honary, S., & Zahir, F. (2013) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v12i2.20 · Cited by 1,309
Liposomes in drug delivery: Progress and limitations
Sharma, A. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00135-x · Cited by 1,253
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control
Yu, L. X. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9511-1 · Cited by 1,191
Raman spectroscopy of lipids: A review
Czamara, K., Majzner, K., Pacia, M. Z., Kochan, K., Kaczor, A., & Baranska, M. (2015) · Journal of Raman Spectroscopy · doi:10.1002/jrs.4607 · Cited by 1,089
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
Das, S., & Chaudhury, A. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-010-9563-0 · Cited by 838
Application of liposomes in medicine and drug delivery
Daraee, H., Etemadi, A., Kouhi, M., Alimirzalu, S., & Akbarzadeh, A. (2016) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.3109/21691401.2014.953633 · Cited by 765
Zylberberg, C., & Matosevic, S. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1177136 · Cited by 627
Composition design and medical application of liposomes
Li, M., Du, C., Guo, N., Teng, Y., Meng, X., Sun, H., Li, S., Yu, P., & Galons, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.007 · Cited by 555
Zeta potential: a case study of cationic, anionic, and neutral liposomes
Smith, M. C., Crist, R. M., Clogston, J. D., & McNeil, S. E. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0527-z · Cited by 479
Application of Various Types of Liposomes in Drug Delivery Systems
Alavi, M., Karimi, N., & Safaei, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.002 · Cited by 466
Immunological and Toxicological Considerations for the Design of Liposomes
Inglut, C. T., Sorrin, A. J., Kuruppu, T., Vig, S., Cicalo, J., Ahmad, H., & Huang, H.-C. (2020) · Nanomaterials · doi:10.3390/nano10020190 · Cited by 371
Progress in nanoparticles characterization: Sizing and zeta potential measurement
Xu, R. (2008) · Particuology · doi:10.1016/j.partic.2007.12.002 · Cited by 344
The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases
Nisini, R., Poerio, N., Mariotti, S., De Santis, F., & Fraziano, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00155 · Cited by 296
Lipid-Based Nanoparticles for Drug Delivery Systems
Samimi, S., Maghsoudnia, N., Eftekhari, R. B., & Dorkoosh, F. (2019) · Characterization and Biology of Nanomaterials for Drug Delivery · doi:10.1016/b978-0-12-814031-4.00003-9 · Cited by 266
Effect of Polymer-Based Nanoparticles on the Assay of Antimicrobial Drug Delivery Systems
Gumustas, M., Sengel-Turk, C. T., Gumustas, A., Ozkan, S. A., & Uslu, B. (2017) · Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics · doi:10.1016/b978-0-323-52725-5.00005-8 · Cited by 196
Stabilization of liposomes during drying
Ingvarsson, P. T., Yang, M., Nielsen, H. M., Rantanen, J., & Foged, C. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.553219 · Cited by 168
Thermal analysis of phase transition behaviour in liposomes
Taylor, K. M. G., & Morris, R. M. (1995) · Thermochimica Acta · doi:10.1016/0040-6031(94)01884-j · Cited by 156
Alomrani, A., Badran, M., Harisa, G. I., ALshehry, M., Alhariri, M., Alshamsan, A., & Alkholief, M. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.02.008 · Cited by 143
Oxidative Stability of Marine Phospholipids in the Liposomal Form and Their Applications
Lu, F., Nielsen, N. S., Timm‐Heinrich, M., & Jacobsen, C. (2010) · Lipids · doi:10.1007/s11745-010-3496-y · Cited by 129
Migliore, M. M., Vyas, T. K., Campbell, R. B., Amiji, M. M., & Waszczak, B. L. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21939 · Cited by 126
How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider
Schellekens, H., Stegemann, S., Weinstein, V., de Vlieger, J. S. B., Flühmann, B., Mühlebach, S., Gaspar, R. S., Shah, V. P., & Crommelin, D. J. A. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9533-z · Cited by 122
Antioxidant activity of quercetin in Eudragit-coated liposomes for intestinal delivery
Caddeo, C., Gabriele, M., Fernàndez‐Busquets, X., Valenti, D., Fadda, A. M., Pucci, L., & Manconi, M. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.007 · Cited by 121
Development of risperidone liposomes for brain targeting through intranasal route
Narayan, R., Singh, M., Ranjan, O. P., Nayak, Y., Garg, S., Shavi, G. V., & Nayak, U. Y. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.033 · Cited by 118
Sikora, A. E., Bartczak, D., Geißler, D., Kestens, V., Roebben, G., Ramaye, Y., Varga, Z., Pálmai, M., Shard, A. G., Infante, H. G., et al. (2015) · Analytical Methods · doi:10.1039/c5ay02014j · Cited by 117
Liposome toxicity in the mouse central nervous system
Adams, D., Joyce, G., Richardson, V. J., et al. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90104-6 · Cited by 111
Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease
Migliore, M. M., Ortiz, R., Dye, S., Campbell, R. B., Amiji, M. M., & Waszczak, B. L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.019 · Cited by 109
Jagwani, S., Jalalpure, S. S., Dhamecha, D. L., Jadhav, K. V., & Bohara, R. A. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00429 · Cited by 107
Liposomes: Preparation, Characteristics, and Application Strategies in Analytical Chemistry
Liu, G., Hou, S., Tong, P., & Li, J. (2020) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2020.1805293 · Cited by 106
Jeon, H. S., Seo, J. E., Kim, M. S., Kang, M. H., Oh, D. H., Jeon, S. O., Jeong, S. H., Choi, Y. W., & Lee, S. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.023 · Cited by 101
Curcumin-In-Deformable Liposomes-In-Chitosan-Hydrogel as a Novel Wound Dressing
Ternullo, S., Schulte-Werning, L. V., Holsæter, A. M., & Škalko‐Basnet, N. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010008 · Cited by 86
Anticonvulsant activity of resveratrol-loaded liposomes in vivo
Ethemoglu, M. S., Şeker, F. B., Akkaya, H., Kılıç, E., Aslan, İ., Erdogan, C. S., & Yılmaz, B. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.026 · Cited by 77
Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery
Lai, W., Wong, W., & Rogach, A. L. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c13504 · Cited by 72
Infrared Spectroscopy of Membrane Lipids
Derenne, A., Claessens, T., Conus, C., & Goormaghtigh, E. (2012) · Springer eBooks · doi:10.1007/978-3-642-16712-6_558 · Cited by 71
Liposomal flucytosine capped with gold nanoparticle formulations for improved ocular delivery
Salem, H. F., Ahmed, S. M., & Omar, M. M. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s91730 · Cited by 66
Rajendran, V., Rohra, S., Raza, M., Hasan, G. M., Dutt, S., & Ghosh, P. C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01796-15 · Cited by 65
Tretinoin-loaded liposomal formulations: from lab to comparative clinical study in acne patients
Rahman, S. A., Abdelmalak, N. S., Badawi, A., Elbayoumy, T., Sabry, N., & El Ramly, A. (2016) · Drug Delivery · doi:10.3109/10717544.2015.1041578 · Cited by 64
Pinilla, C. M. B., Reque, P. M., & Brandelli, A. (2020) · Food and Bioprocess Technology · doi:10.1007/s11947-020-02419-8 · Cited by 64
Liposomes augment biological benefits of curcumin for multitargeted skin therapy
Ternullo, S., Gagnat, E., Julin, K., Johannessen, M., Basnet, P., Vanić, Ž., & Škalko‐Basnet, N. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.09.016 · Cited by 60
Sharma, S., Rajendran, V., Kulshreshtha, R., & Ghosh, P. C. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.07.079 · Cited by 59
De, M., Ghosh, S., Sen, T., Shadab, M., Banerjee, I., Basu, S., & Ali, N. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.10.019 · Cited by 57
Berberine-Loaded Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice
Calvo, A., Moreno, E., Larrea, E., Sanmartín, C., Irache, J. M., & Espuelas, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090858 · Cited by 55
Csóka, I., Pallagi, E., & Paál, T. L. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.03.012 · Cited by 50
Self-citationAn Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development
Németh, Z., Pallagi, E., Dobó, D. G., Kozma, G., Kónya, Z., & Csóka, I. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071071 · Cited by 49
Self-citationIngle, S. G., Pai, R. V., Monpara, J. D., & Vavia, P. R. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.06.025 · Cited by 44
Tran, B. H., Yu, Y., Chang, L., Tan, B., Jia, W., Xiong, Y., Dai, T., Zhong, R. M., Zhang, W., Le, V. M., et al. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s216667 · Cited by 43
Vhora, I., Lalani, R., Bhatt, P., Patil, S., Patel, H., Patel, V., & Misra, A. R. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1161-6 · Cited by 37
A Proposed Methodology for a Risk Assessment-Based Liposome Development Process
Németh, Z., Pallagi, E., Dobó, D. G., & Csóka, I. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121164 · Cited by 32
Self-citationLiposomes as potential carriers for ketorolac ophthalmic delivery: formulation and stability issues
Mehanna, M. M., El-Kader, N. A., & Samaha, M. W. (2017) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902017000216127 · Cited by 29
Kumar, N., Rai, A., Reddy, N. D., Shenoy, R. R., Mudgal, J., Bansal, P., Mudgal, P. P., Arumugam, K., Udupa, N., Sharma, N. K., et al. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.03.013 · Cited by 26
Effect of Cationic Lipid Nanoparticle Loaded siRNA with Stearylamine against Chikungunya Virus
Jeengar, M. K., Kurakula, M., Patil, P., More, A. N., Sistla, R., & Parashar, D. (2022) · Molecules · doi:10.3390/molecules27041170 · Cited by 26
He, K., Liu, J., Gao, Y., Hao, Y., Yang, X., & Huang, G. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-019-1586-6 · Cited by 25
Sipos, B., Katona, G., & Csóka, I. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050702 · Cited by 24
Self-citationTogami, K., Maruta, Y., Nanbu, M., Tada, H., & Chono, S. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1825473 · Cited by 19
Liposomes in Drug Delivery: Status and Advances
Hu, Y., Ju, R.-J., Zeng, F., Qi, X., & Lü, W.-L. (2021) · Biomaterial engineering · doi:10.1007/978-3-662-49320-5_1 · Cited by 17
Togami, K., Daisho, T., Yumita, Y., Kitayama, A., Tada, H., & Chono, S. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.03.032 · Cited by 13
Cationic Liposomes Cause ROS Generation and Release of Neutrophil Extracellular Traps
Lotosh, N. Y., Alyaseva, S. O., Малашенкова, И. К., Sorokoumova, G. M., Vasilov, R. G., & Selischeva, A. A. (2019) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747818040074 · Cited by 10
Lotosh, N. Y., Alyaseva, S. O., Vasilov, R. G., & Селищева, А. А. (2019) · Cell and Tissue Biology · doi:10.1134/s1990519x19050055 · Cited by 4
Metadata
- Authors
- Németh, Z., Csóka, I., Semnani Jazani, R., Sipos, B., Haspel, H., Kozma, G., Kónya, Z., & Dobó, D. G.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2022-08-26
- Volume
- 14
- Issue
- 9
- Pages
- 1798
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W4293769852
- Cited by
- 452
- References
- 65
- FWCI
- 14.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.